# Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa

> **NCT02216071** · PHASE3 · COMPLETED · sponsor: **Exela Pharma Sciences, LLC.** · enrollment: 499 (actual)

## Conditions studied

- Acute Otitis Externa

## Interventions

- **DRUG:** Ciprodex®
- **DRUG:** EXL CDOS (Ciprofloxacin 0.3% and Dexamethasone 0.1%) Sterile Otic Suspension

## Key facts

- **NCT ID:** NCT02216071
- **Lead sponsor:** Exela Pharma Sciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-20
- **Primary completion:** 2015-08-11
- **Final completion:** 2015-08-11
- **Target enrollment:** 499 (ACTUAL)
- **Last updated:** 2021-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216071, "Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02216071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*